FMD

News story: Queen Mary collaborates to open new, world-class dental training clinic

Queen Mary University of London, in partnership with the London Borough of Barking and Dagenham Council, has announced the opening of a new, cutting-edge academic dental centre in central Barking.

News story: New personalised risk score could improve ovarian cancer detection

‘Ovatools’ combines blood test results and age to identify women at higher risk of ovarian cancer for further testing and referral, improving accuracy and patient outcomes cost-effectively.  

News story: Professor Sir Mark Caulfield awarded medal from the Embassy of Kuwait to recognise contributions to UK-Kuwait relations

Professor Sir Mark Caulfield was today awarded one of 125 medals from the Kuwaiti Cultural Office, recognising his excellence in the fields of medical sciences and his key role in developing a partnership between Kuwait and Queen Mary University of London. 

News story: Study shows dual use of cigarettes and vapes can reduce risks of smoking and help smokers quit

A new major study from Queen Mary University of London has found that smokers who use both cigarettes and e-cigarettes at the same time – known as dual use – are reducing their intake of harmful chemicals and are also more likely to eventually quit smoking than those who continue to smoke only. This challenges common fears about dual use. 

News story: Human hair grows through ‘pulling’ not push – study

A new imaging study overturns long-held assumption about how hair grows and may open doors to future treatment for hair loss.

News story: Advancing equity through inclusive HIV research

As we mark World AIDS Day, this year’s theme ‘Overcoming disruption, transforming the AIDS response’ stresses the need to protect progress in HIV prevention and treatment amid global uncertainty. Service disruptions, widening health inequalities and shifting policy environments all threaten hard-won gains. Meeting these challenges require a commitment to equity at every stage of the HIV response. 

News story: New study warns of alarming decline in high blood pressure control in England

A comprehensive new analysis by researchers at Queen Mary University of London warns that England has lost the substantial gains made in high blood pressure prevention, diagnosis and management during the 2000s.

News story: Newham Councillor recruited to landmark study for people from Black backgrounds in UK

Councillor Odoi provided a saliva sample at Queen Mary University of London’s Whitechapel campus, one of many research sites across London. 

News story: Family clues could help predict how we react to antidepressants

A new study from Queen Mary University of London shows that a family’s experience with certain medicines could help doctors predict how future generations will respond to the same drugs. 

News story: Queen Mary Institute of Dentistry welcomes Iraqi postgraduate students

On Wednesday 5 November 2025, Professor Christopher Tredwin, Dean and Director at the Institute of Dentistry, hosted the Cultural Attaché of the Republic of Iraq in the United Kingdom, Professor Dr. Qusay Kamal Al-Din Al-Ahmadi.  

News story: Queen Mary celebrates William Harvey Day

William Harvey Day 2025 saw over 300 attendees gather to celebrate the best of research within the Faculty of Medicine and Dentistry at Queen Mary University of London alongside our partners, St Bartholomew's Hospital, the Worshipful Society of Apothecaries and Barts Charity. 

News story: Queen Mary grants exclusive patent license to Salt Hill to advance novel Treg activation technology

The technology opens the door to developing a wide range of new treatments for autoimmune and inflammatory diseases

News story: CtDNA-guided adjuvant therapy with atezolizumab improves survival outcomes in patients with muscle-invasive bladder cancer

New findings from researchers at Queen Mary University of London, presented at the European Society for Medical Oncology (ESMO) Congress 2025, could improve survival for people with bladder cancer.  

News story: Queen Mary University of London launches new spinout Procyon Diagnostics to provide early cancer tests

Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed pre-seed round. The new company aims to become a leading provider of biomarker technologies for early cancer detection.

News story: Apple-Tree intervention offers hope and support for people facing memory loss

Results from a six-year £5 million study led by researchers at Queen Mary University of London, show that a new low intensity group therapy, “APPLE-Tree”, helps people living with memory loss to address dementia risk factors.1

News story: Hormone replacement therapy may help restore immunity in menopausal women

A study led by researchers at Queen Mary University of London has found that hormone replacement therapy (HRT) may help reverse changes in the immune system caused by menopause, potentially booting immune health. The research reveals new evidence that menopause significantly alters women’s immune system, increasing their vulnerability to infections. 

News story: Research shows masks can prevent airborne pollutants from entering bloodstream

Researchers have found the first direct evidence that tiny particles of air pollution stick to our red blood cells, meaning they can travel freely around the body.

News story: Early symptoms of MS same across ethnic and social groups – study

A major UK study has revealed that the early warning signs of multiple sclerosis (MS) - including pain, mood changes, and neurological symptoms such as numbness and tingling – may appear years before diagnosis and affect all communities in similar ways.

News story: Queen Mary trials new approach to drug development for rare diseases

Queen Mary researchers led by Dr. Emanuel Rognoni and Dr. Matthew Caley, with backing from DEBRA Research, have begun a new initiative to accelerate drug development for Epidermolysis bullosa (EB), a rare skin disease with devastating impact. 

News story: ‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes – known as extrachromosomal DNA, or ecDNA – can drive the growth of a large proportion of glioblastomas, the most common and aggressive adult brain cancer.

News story: Queen Mary students claim top honours in the University of London Gold Medal Competition 2025

Queen Mary students won three of the four awards at the annual competition, which recognises outstanding medical and dental students from London-based universities.

News story: Breakthrough life-extending treatment for advanced bladder cancer available on NHS

The new combination treatment offers hope to thousands of people living with advanced urothelial cancer. The clinical trials, led by Queen Mary University of London’s Professor Tom Powles, showed overall survival rates were almost twice as long with this new treatment compared to the current standard treatment.

News story: KidneyGenAfrica: a pan-African partnership to deliver research and training excellence in genomics of kidney disease

Queen Mary's PHURI is a founder member of a new pan-African partnership which aims to deliver research and training excellence in genomics of kidney disease. In a comment published in Nature Genetics today, the team outlines the urgent need for such a consortium in Africa and the framework they have developed to make it a reality.

News story: How immune cells communicate to fight disease and cancer 

An interdisciplinary team of scientists from the Berlin Institute of Health at Charité (BIH), the Max Delbrück Center, the German Cancer Research Center (DKFZ), the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) and Queen Mary University of London has developed a technology to decode immune cell communication.  

News story: Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer

Home-testing kits for HPV will soon be offered to women in England who are overdue for cervical cancer screening, giving women the option to stay up to date with cervical screening without having to have an internal examination. 

News story: When should preventive mastectomy be offered for women at higher risk of breast cancer

More women at higher risk of breast cancer should be offered a mastectomy, according to researchers at Queen Mary and London School of Hygiene and Tropical Medicine.

News story: A breath test could help us detect blood cancers

Molecules exhaled in the breath may help detect blood cancer, according to new research from Queen Mary University of London. The findings could enable the development of a blood cancer breathalyser, providing a rapid, low-cost way to detect disease. This tool may be particularly useful for areas with limited access to specialist equipment or expertise. 

News story: Short-term digital mental health interventions reduces depression and anxiety in Ukrainian children and adolescents displaced by war

In a first of its kind randomised controlled trial, researchers found delivering a problem solving digital mental health intervention to young Ukrainian refugees significantly reduced symptoms of depression and anxiety. The findings show that a small, low-cost, scalable intervention delivered in schools through mobile devices may support the mental health of millions of displaced young people.

News story: New drug offers hope of cure for hormone-driven high blood pressure

The commonest single cause of high blood pressure can be reversed with a new class of medicine, according to results from a clinical trial led by Queen Mary University of London. 

News story: New understanding of how red blood cells are created could make artificial blood easier to make

Studies undertaken by researchers at Queen Mary and University of Konstanz have identified a critical chemical signal in the development of red blood cells. The discovery will help make the manufacture of artificial blood more efficient.

News story: New drug tackles uncontrolled hypertension caused by aldosterone dysregulation

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces systolic blood pressure in adults with uncontrolled hypertension (uHTN) or resistant hypertension (rHTN).

News story: Professor Sir Jack Cuzick awarded CRUK's inaugural Outstanding Achievement in Cancer Prevention Research Award

Professor Cuzick has been honoured for his exceptional and sustained contributions to the field of prevention research. His research has made transformative contributions to cancer prevention on a global scale.

News story: Women will receive home testing kits for cervical cancer, a move informed by Queen Mary research

Queen Mary’s research on self-sampling for cervical cancer was highly influential in the decision to offer home testing kits for cervical cancer screening, which has been announced today as part of the upcoming NHS 10 Year Plan.

News story: New research identifies four epidemiological stages of Inflammatory bowel disease (IBD)

The research, published in Nature, gives an opportunity for health-care systems to pinpoint where their region sits on this trajectory and provides a clear roadmap for anticipating and managing the growing burden of IBD today and in the future.

News story: Largest twin study explores whether the environment affects people differently depending on their genes

An international team including researchers from Queen Mary have identified genetic factors that may make some individuals more or less sensitive to the environments they experience.

News story: Antibiotics taken during pregnancy may reduce preterm births

A study of almost 1000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive antibiotic may have led to fewer babies being born early. Among women living with HIV, those who received the antibiotic had larger babies who were less likely to be preterm.

News story: New injection could help millions with high blood pressure

Results from a clinical trial led by researchers from Queen Mary University of London, published yesterday in JAMA, show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure.

News story: Professor Claudia Langenberg and Professor Jonathan Grigg elected as Fellows of the Academy of Medical Sciences

Two Professors from Queen Mary join 54 exceptional biomedical and health scientists elected by the Academy to its prestigious Fellowship.

News story: Beyond ‘one size fits all’: Study reveals ethnic differences in breast cancer development and outcomes, demanding tailored care approaches

Women of African or South Asian genetic ancestry tend to develop breast cancer and die at a younger age than women of European ancestry, according to new research by Queen Mary University of London. The study also found important genetic differences in these women’s cancers that could impact their diagnosis and treatment.

News story: Professor Morris Brown elected as Fellow of the Royal Society

Professor Morris Brown MD FRCP FMedSci FRS has been elected to the Fellowship of the Royal Society, the UK’s national academy of sciences. He is one of 90 outstanding scientists from the UK and internationally who have joined the prestigious body this year.

News story: Dementia Action Week: the importance of a timely diagnosis

As many as 1 in 4 men and 1 in 3 women will develop dementia in their lifetime. Getting a timely diagnosis is important as it allows people to understand and get treatment for their symptoms, access help and support, and plan for the future.

News story: New report highlights the role of community engagement in reducing health inequalities for Black African and Black Caribbean communities in the UK

The report by the Partnership for Black People’s Health (PBPH) highlights the urgent need for culturally appropriate health interventions, a demand for greater representation, and the necessity for Black-led initiatives within healthcare. 

News story: Centre for Bone and Joint Health established at Queen Mary

The Centre for Bone and Joint Health at Queen Mary brings together experts across musculoskeletal care to drive research that improves the health of people with bone and joint disorders and injuries.

News story: New study sheds light on health differences between sexes

The results of an international study led by researchers from Queen Mary University of London’s Precision Healthcare University Research Institute (PHURI) shed new light the underlying biological mechanisms which cause differences in health risks, symptoms and outcomes between males and females.  

News story: New combination treatment could extend the lifetime of people with amyotrophic lateral sclerosis (ALS)

The results of the MIROCALS randomised clinical trial showed that adding low-dose interleukin-2 (IL2LD) to standard treatment for this degenerative disorder slowed functional decline and extended the lifespan of people with ALS.

News story: Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

A single blood test for the chemical signals of many different types of cancer could detect the disease at its early stages, making it easier to treat for almost 50% of patients

News story: New algorithms can help GPs predict which of their patients have undiagnosed cancer

Two new advanced predictive algorithms use information about a person’s health conditions and simple blood tests to accurately predict a patient’s chances of having a currently undiagnosed cancer, including hard to diagnose liver and oral cancers. 

News story: A new era for healthy ageing: ACHA launches in North East London

The Academic Centre for Healthy Aging (ACHA) is a landmark collaboration between Barts Health NHS Trust, Queen Mary University of London, and Barts Charity, focused on improving the health, wellbeing, and care of older adults in north-east London and beyond.

News story: Breakthrough approach for diagnosing TB could significantly improve detection

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not always accurately detect disease.

News story: Queen Mary research leads the way in tackling tuberculosis

Researchers at Queen Mary are building on many years of ground-breaking studies into tuberculosis (TB) to reveal new insights into this disease and its long-term effects.

News story: Professor Sir Mark Caulfield elected member of the Medical Research Council

Professor Caulfield, Vice-Principal (Health) at Queen Mary, joins twelve other senior figures from health, science, and medicine on the Council.

News story: Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications

A new study from Queen Mary University of London found that 9% of all adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before prescribing could therefore help avoid ADRs in these cases. 

News story: Underfunding may contribute to higher mortality for patients in Latin America receiving surgery

An international study of the health outcomes of people receiving surgery across 17 Latin American countries found 1 in 7 developed significant complications leading to longer hospital stays and a greater risk of death.

News story: Why lived experience is so important: a review of Patient and Public involvement in health research

Heather Mah from the Wolfson Institute of Population Health has conducted a review of Patient and Public Involvement (PPI) in health research in the UK. In her scoping review, she critically examined how PPI benefits both people with lived experience and researchers, and on the impact taking part can have on participants.

News story: Study reveals early dementia symptoms may vary across different ethnicities

People from different ethnic backgrounds may report physical symptoms rather than purely cognitive difficulties, leading to delays in the diagnosis of dementia. 

News story: Improved emergency and critical care could save lives of critically ill patients in Africa

An international study of acute hospitals across Africa found a large and neglected burden of critical illness, and a high incidence of preventable deaths due to issues with the provision of basic critical care. 

News story: Queen Mary University of London to lead £1.8M study looking at AI in emergency care

The University will lead the study which aims to support clinical decision-making with AI insights to enhance emergency life-saving care. 

News story: Queen Mary University of London co-leads £43.6m initiative to accelerate AI-powered cancer breakthroughs

Queen Mary University of London will co-lead a ground-breaking collaboration that aims to harness cutting-edge artificial intelligence (AI) and unlock decades of NHS cancer data. Today, the UK government is committing £18.9 million to the project, bringing the total investment to £43.6 million when combined with contributions from charities, industry partners, and public research organisations. 

News story: Almost 90% of people would agree to genetic testing to tailor medication use, survey finds

New research from Queen Mary University of London shows that almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects.

News story: London’s ULEZ is changing the school run

A new study highlights the benefits of ULEZ with many families noticing cleaner air and safer roads. However, it also reveals challenges, particularly for those living in outer boroughs who are more reliant on the car and may struggle to adapt.

News story: From height to health: largest global genetic study reveals hidden risks and benefits linked to stature

New genetic links have been discovered between genetically-predicted height and an individual’s likelihood of developing a range of diseases and conditions. These new data could help improve early diagnosis and risk monitoring for patients.

News story: Landmark study finds 69 previously unidentified genetic determinants of rare disease

The breakthrough research led by Queen Mary University of London uses a new analytical approach for identifying the genetic basis of rare diseases, which could diagnose more cases and help develop new treatments for patients. 

News story: New treatment offers quick cure for common cause of high blood pressure

A revolutionary new treatment called Targeted Thermal Therapy (Triple T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal disorder. 

News story: New dementia care programme could save NHS £9,000 per person

The NIDUS-Family package of care uses goal setting to help people with dementia live well at home for longer. New research from Queen Mary University of London in collaboration with UCL shows that, in addition to these known benefits, NIDUS-Family also reduces the costs associated with providing support to people with dementia.

News story: Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells

New research led by Queen Mary’s Institute of Dentistry has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumour growth. 

News story: Queen Mary's Institute of Dentistry receives Athena Swan silver award

The award recognises the Institute's continuing commitment and achievements in gender equality.

News story: Professor Ian Curran joins the Faculty of Medicine and Dentistry as the new Dean for Education

Professor Curran will bring a wealth of international experience to the role, affirming the Faculty’s place at the forefront of medical education.

News story: Professor Nikos Donos awarded Fellowship in Dental Surgery in hominem at the Royal College of Surgeons of Edinburgh

Professor Nikolaos Donos was elected at a meeting of the Council of the College in November 2024.

News story: Professor Julia Hippisley-Cox appointed as Professor of Clinical Epidemiology and Predictive Medicine

Queen Mary University of London is delighted to announce the appointment of Professor Julia Hippisley-Cox as the inaugural Professor of Clinical Epidemiology and Predictive Medicine in the Wolfson Institute of Population Health. She will join the University from the beginning of February.

News story: Dr John Ford: How machine learning can inform impactful policies to improve health equity

Dr John Ford is a Senior Clinical Lecturer in Health Equity in Queen Mary’s Wolfson Institute of Population Health. This week, Dr Ford joins Evidence Week in Parliament to demonstrate how ‘Living Evidence Maps’ can help policy makers find the high-impact ideas within large bodies of evidence.

News story: Late-life depression could be an early indicator of dementia

A new study examining the connection between depression and dementia provides critical insights into how depression might be both a risk factor for and an early sign of dementia.

News story: UK Biobank launches the world’s largest protein study to unlock new medical breakthroughs

Research led by Queen Mary’s Professor Claudia Langenberg and her team has helped to prove the effectiveness of large-scale protein studies using UK Biobank data to understand disease 

News story: Queen Mary launches new spinout Elcella to provide natural alternative to weight-loss drugs

Queen Mary University of London has launched a new spinout company, Elcella, founded by Dr Madusha Peiris and Dr Rubina Aktar. Their unique nutrient-based appetite suppressant stimulates your body’s natural ability to control your eating – based on a decade of scientific research.

News story: Doctors warn against fluid therapy approach in surgery after global trial

A major study aiming to improve outcomes from higher risk operations has ruled out a fluid therapy approach during surgery.

News story: Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease.  

News story: New protocol for testing self-collected samples for cervical screening could reduce the need for clinician sampling in many cases

A new protocol for the analysis of self-collected cervical samples could reduce the need for follow-up clinician screening for many women, and result in more rapid referral for gynaecology assessment for others. This could improve cervical cancer screening procedures in the NHS.